What Would Happen If The Entire Bethel Family At Governing Body Central Was MicroDosed With Magic Mushrooms Over A One Year Period?
by frankiespeakin 60 Replies latest admin removed
-
-
Vidiot
Honestly, I think at this point, the GB'd be immune even to the effects of Ecstasy.
-
-
frankiespeakin
I'm sure morning worship (corporation pep talks) at bethel would be filled with a lot of WTF moments if people there were given micro doses over an extended period of time, and this would create a noticible under current of growing detestation towards the the Governing Body's encouragement towards corporation worship.
The way I see it is that it reroutes the direction that the neurons are firing thus new thoughts instead of the same old bull shit they have been feasting on at head quarters, these new ideas start forming and can become integrated with the personality and pretty soon the Governing Body start looking like the delusional goons that they really are, all obsessed with with their bull shit biblical authority and what not.
-
-
-
-
-
-
frankiespeakin
http://www.maps.org/news-letters/v11n2/11222gro.html
Stanislav Grof interviews Dr. Albert Hofmann
Esalen Institute, Big Sur, California, 1984Editor's note: This remarkable dialogue from 1984 has never been published. We're printing it now in part to provide historical context for a new effort, in which MAPS is participating, to restart LSD psychotherapy research in the United States. In addition, this dialogue addresses and helps clarify the idealist view of the potential value of psychedelics, when used properly, to help "engender ecological sensitivity, reverence for life, and capacity for peaceful cooperation with other people and other species," qualities that are desperately needed in these times of terrorism and war.
PDF version of this documentGrof: It is a great pleasure and an honor for me this morning to welcome and introduce Dr. Albert Hofmann, to the extent to which he needs introduction at all. As you all know, he became world famous for his discovery of a compound that is probably the most controversial substance ever developed by man, diethylamide of lysergic acid, or LSD-25. When LSD made its entry into the world of science, it became an overnight sensation because of its remarkable effects and also its unprecedented potency. It seemed to hold tremendous promise in the research of the nature and etiology of schizophrenia, as an extraordinary therapeutic agent, as a very unconventional tool for training of mental health professionals, and as a source of inspiration for artists.
Dr. Hofmann's discovery of LSD generated a powerful wave of interest in brain chemistry and, together with the development of tranquilizers, was directly responsible for what has been called the "golden age of psychopharmacology." And then his prodigious child became a "problem child". This extraordinarily promising chapter in psychology and psychiatry was drastically interrupted by unsupervised mass self-experimentation and the ensuing repressive administrative, legislative, and political measures, as well as the chromosome scare and the abuse by the military and secret police. But I firmly believe that this chapter is far from being closed. Whether or not LSD research and therapy as such will return into modern society, the discoveries that psychedelics made possible have profound revolutionary implications for our understanding of the psyche, human nature, and the nature of reality. And these new insights are here to stay as an important part of the emerging scientific world view of the future.
Before we start this interview, I would like to add a little personal note. Dr. Hofmann's discovery of LSD and his work, in general, have had a profound impact on my own professional and personal life, for which I am immensely grateful. My first LSD session in 1956, when I was a beginning psychiatrist, was a critical landmark and turning point for me and since then my life has never been the same. So this interview gives me the opportunity to express my deep appreciation and gratitude to Dr. Hofmann for the influence he has had on my life. What I would like to ask you first has something to do with the way people tend to qualify your discovery of the psychedelic effects of LSD. It is usually referred to as a pure accident, implying that there was nothing more involved in this entire matter than your fortuitous intoxication. But I know from you that the history was somewhat more complex than that. Can you clarify this for us?Hofmann: Yes, it is true that my discovery of LSD was a chance discovery, but it was the outcome of planned experiments and these experiments took place in the framework of systematic pharmaceutical, chemical research. It could better be described as serendipity. That means that you look for something, you have a certain plan, and then you find something else, different, that may nevertheless be useful.
And that is exactly what happened with LSD. I had developed a method for the synthesis of lysergic acid amides in the context of a systematic study, the purpose of which was to synthesize natural ergot alkaloids. At that time, in the 1930s, a new ergot alkaloid had been discovered which is named ergometrine, or ergonovine. It is the real active principle of ergot. The presence of this alkaloid in ergot is the reason why it has been used in obstetrics to stop uterine bleeding and as an oxytoxic. And this substance turned out to be an amide of lysergic acid.
Until the late 1930s, it had not been possible to prepare such substances in the laboratory. I discovered a technical procedure that made it possible and was able to achieve partial synthesis of ergonovine; I then also used this procedure to prepare other lysergamides. First came the modifications of ergonovine and one of these modifications, methergine, a homologue of ergonovine, is today the leading medicament in obstetrics to stop postpartum bleeding. I also used this procedure to prepare not so close derivatives of ergonovine, more different than methergine. And one of these compounds was LSD-25, lysergic acid diethylamide. The plan, the intention I had, was to prepare an analeptic, a circulatory and breathing stimulant.Grof: Was there some indication in the early animal experiments that LSD could be an activating agent?
Hofmann: No, I made LSD because it is an analog of coramine, which is diethylamide of nicotinic acid. Because of the structural relationship between LSD and the ring of the nicotinic acid, I hoped to get an analeptic. But our pharmacologist concluded that lysergic acid diethylamide did not have any clinically interesting properties and suggested that it be dropped out of research. That happened in the year 1938. But all along, I had a strange feeling that we should again test this substance on a broader scale. Then, five years later, in 1943, I finally decided to synthesize another sample of LSD. At the end of the synthesis, something very strange happened. I got into a dreamlike condition, in which all of my surrounding was transforming. My experience of reality had changed and it was rather agreeable. In any case, I left the laboratory, went home, lay down and enjoyed a nice dreamlike state which then passed away......